Skip to main content
profile image
Selected Works of Reshma Mahtani
Article
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Journal of Clinical Oncology (2021)
  • Reshma Mahtani, Baptist Health South Florida
  • Bryan Schneider
  • Guanglong Jiang
  • Tarah J. Ballinger, Indiana University
  • Fei Shen
  • Christopher Chitambar
  • Rita Nanda, University of Chicago
  • Carla Falkson
  • Filipa C. Lynce
  • Christopher Gallagher
  • Claudine Isaacs, Icahn School of Medicine at Mount Sinai
  • Marcelo Blaya, East Jefferson General Hospital
  • Elisavet Paplomata
  • Radhika Walling
  • Karen Daily
  • Michael Thompson
  • Robert Graham
  • Maureen E. Cooper
  • Dean C. Pavlick
  • Jeffrey Gregg
  • Jeffrey P. Solzak
  • Yu-Hsiang Chen
  • Casey L. Bales
  • Erica Cantor
  • Bradley A. Hancock
  • Nawal Kassem
  • Paul R. Helft, Indiana University
  • Bert H. O'Neil, Indiana University
  • Anna Maria V. Storniolo
  • Sunil Badve
  • Kathy Miller
  • Milan Radovich
Link
Disciplines
Publication Date
2021
Citation Information
Reshma Mahtani, Bryan Schneider, Guanglong Jiang, Tarah J. Ballinger, et al.. "BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer" Journal of Clinical Oncology Vol. 40 Iss. 4 (2021)
Available at: http://works.bepress.com/reshma-mahtani/99/